Furthermore, we analyzed the potential association of the percentages of circulating CD14+CD169+ monocytes and TIMs with the levels of cytokines and CEA as well as the clinical parameters in CRC patients. The gene discussed is SIGLEC1; the disease is colorectal carcinoma.